CBS 2019
CBSMD教育中心
中 文

经皮左心耳封堵

Abstract

Recommended Article

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants: A Nationwide Propensity Score–Weighted Study Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure Results From the CABANA Trial Does pulsed field ablation regress over time? A quantitative temporal analysis of pulmonary vein isolation Percutaneous Left Atrial Appendage Occlusion for Patients in Atrial Fibrillation Suboptimal for Warfarin Therapy: 5-year Results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation 2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview

Original ResearchVolume 73, Issue 9, March 2019

JOURNAL:J Am Coll Cardiol. Article Link

von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week

EV Belle, F Vincent, A Rauch et al. Keywords: aortic stenosis; biomarker; bioprosthesis; heart valve disease; mitral regurgitation; paravalvular regurgitation; point-of-care test; TAVR

FULL TEXT PDF